v3.26.1
Equity Incentive Plan Grants
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plan Grants

Note 8. Equity Incentive Plan Grants

 

The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) was originally approved by the Company’s stockholders on October 1, 2021, and has subsequently been amended, most recently pursuant to Amendment No. 3 approved by stockholders on July 23, 2025, to increase the number of shares authorized for issuance under the 2021 Plan to 2.0 million shares. The purpose of the 2021 Plan is to attract and retain directors, consultants, officers and other key employees of the Company and its subsidiaries and to provide to such persons incentives and rewards for superior performance. The 2021 Plan is administered by the Compensation and Management Resources Committee of the Board and has a term of ten years. The 2021 Plan awards may be in the form of stock options (which may be incentive stock options or nonqualified stock options), stock appreciation rights (“SARs”), restricted shares, RSUs, and other share-based awards. As of March 31, 2026, there were approximately 2.0 million shares remaining available for future issuance.

 

In addition, on March 24, 2023, the Board approved an employee stock purchase plan (“FGF ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after thirty days of employment.

 

Stock-based compensation expense for the three months ended March 31, 2026 and March 31, 2025 was approximately $0.1 million and $0.2 million, respectively. As of March 31, 2026, total unrecognized stock compensation expense of approximately $16 thousand remained, all of which related to stock options, and will be recognized through June 2028.

 

 

Restricted Stock Units

 

There were no unvested RSUs outstanding as of December 31, 2025, and there were no RSU grants during the three months ended March 31, 2026.

 

Stock Options

 

The following table summarizes activity for stock options for the three months ended March 31, 2026:

 

Common Stock Options  Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (yrs)   Weighted Average Grant Date Fair Value  

Aggregate Intrinsic

Value

 
Outstanding, December 31, 2025   3,200   $394.06    4.0   $190.49   $      – 
Granted   –    –          –       
Exercised   –    –          –       
Expired   –    –          –       
Forfeited   –    –          –       
Outstanding, March 31, 2026   3,200   $394.06    3.8   $190.49   $– 
Exercisable, March 31, 2026   2,016   $389.03    3.1   $170.07   $–